SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-017532
Filing Date
2023-01-27
Accepted
2023-01-27 16:06:02
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d421600ddefa14a.htm DEFA14A 62817
2 GRAPHIC g421600g0127210900819.jpg GRAPHIC 4621
3 GRAPHIC g421600g0127210901353.jpg GRAPHIC 5190
  Complete submission text file 0001193125-23-017532.txt   77867
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35238 | Film No.: 23562780
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences